Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830699 · ClinicalTrials.gov registry record · NA
Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis
A NA study of Subacromial Bursitis, sponsored by Keesler Air Force Base Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT01830699 is a NA study of Subacromial Bursitis that has completed, run by Keesler Air Force Base Medical Center. The registered enrollment target is 33 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01830699, a NA study of Subacromial Bursitis, has completed, sponsored by Keesler Air Force Base Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
To date no trials have been performed looking at whether or not intra-bursal injection of an IL-1 antagonist provides pain relief similar to that of a corticosteroid injection. The subcutaneous injection of anakinra, an IL-1 receptor antagonist, in patients with shoulder pain due to rotator cuff tendonitis and subacromial bursitis was efficacious in relieving pain but this information was presented as a case series in a letter to the editor format, so the validity of these results would require additional testing \[Omoigui S, et al. 2004\]. Based mainly on the data from the intra-articular administration of anakinra, there have not been any adverse trends in outcomes or safety to suggest that intra-bursal injection of rilonacept will carry an increase risk of adverse events. The purpose of this trial is to compare the improvement in pain and function of patients with clinical symptoms and signs of subacromial bursitis of rilonacept vs. corticosteroid injection (standard of care).
Conditions Studied
Interventions
- DRUG Corticosteroid
- DRUG Rilonacept
Study Locations (1)
Mississippi
- Keesler Medical Center - Keesler Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830699
The ClinicalTrials.gov registry entry for NCT01830699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Keesler Air Force Base Medical Center, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Subacromial Bursitis appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid is the first listed.
NCT01830699 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.
Frequently Asked Questions
What is clinical trial NCT01830699 about?
NCT01830699 is a clinical study titled "Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis". To date no trials have been performed looking at whether or not intra-bursal injection of an IL-1 antagonist provides pain relief similar to that of a corticosteroid injection. The subcutaneous injection of anakinra, an IL-1 receptor antagonist, in patients with shoulder pain due to rotator cuff ten...
What is the current status of trial NCT01830699?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2013-03. Estimated completion is 2014-03.
What conditions does trial NCT01830699 study?
This clinical trial studies the following conditions: Subacromial Bursitis.
What interventions are being tested in trial NCT01830699?
The interventions under investigation include: Corticosteroid (DRUG), Rilonacept (DRUG).
Who is sponsoring clinical trial NCT01830699?
This trial is sponsored by Keesler Air Force Base Medical Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01830699 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.